Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of Tuesday, September 1, 2026.
EBITDA YIELD
N/A
Scholar Rock Holding Corporation
Market Cap
$6.81B
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.60B
EBITDA Yield
1.22%
TTM Avg
1.72%
3Y Avg
1.16%
5Y Avg
1.16%
Market Cap
$5.41B
EBITDA Yield
5.80%
TTM Avg
6.30%
3Y Avg
5.15%
5Y Avg
4.71%
Market Cap
$10.04B
EBITDA Yield
4.76%
TTM Avg
4.14%
3Y Avg
4.25%
5Y Avg
4.76%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Scholar Rock Holding Corporation (SRRK) | $6.81B | N/A | N/A | N/A | N/A |
| Chemed Corporation (CHE)vs › | $6.78B | 5.73% | 6.48% | 5.46% | 5.41% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.60B | 1.22% | 1.72% | 1.16% | 1.16% |
| Oscar Health, Inc. (OSCR)vs › | $7.77B | 10.28% | 3.00% | 3.34% | 3.34% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.41B | 5.80% | 6.30% | 5.15% | 4.71% |
| Doximity, Inc. (DOCS)vs › | $5.00B | 4.37% | 4.16% | 3.09% | 2.45% |
| The Ensign Group, Inc. (ENSG)vs › | $10.04B | 4.76% | 4.14% | 4.25% | 4.76% |
| Henry Schein, Inc. (HSIC)vs › | $10.23B | 7.81% | 8.62% | 8.47% | 8.64% |
| Insulet Corp. (PODD)vs › | $10.30B | 5.79% | 3.67% | 2.48% | 1.79% |
| Universal Health Services, Inc. (UHS)vs › | $10.31B | 17.61% | 15.20% | 12.81% | 12.60% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
